02 Jul 2024
// PRESS RELEASE
23 May 2024
// PRESS RELEASE
13 May 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
About
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
CORPORATE CONTENT #SupplierSpotlight
02 Jul 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/bioiberica/bioiberica-obtains-self-determined-gras-status-collavant-n2-native-type-ii-collagen-unlocking-new-opportunities-us
23 May 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/heparina/ensuring-availability-medicines-all-key-we-are-part-critical-medicines-alliance
13 May 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/healthcare/our-hyaluronic-acid-matrix-ingredient-dermial-demonstrates-unique-skin-glow-effect-randomized-clinical-trial
23 Apr 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/bioiberica/bioiberica-we-engage-strategic-collaborations-lead-increased-innovation
08 Apr 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/healthcare/women-only-clinical-study-reveals-our-collavant-n2-native-undenatured-type-ii-collagen-shows-joint-health-benefits-40-mg
11 Mar 2024
// PRESS RELEASE
https://www.bioiberica.com/en/media/news/salud-vegetal/bioiberica-launches-new-probiotic-biostimulant-terra-sorb-symbiotic-optimization-fertilization
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 17838
Submission : 2004-11-03
Status : Active
Type : II
Registration Number : 302MF10020
Registrant's Address : C/Antic Cami de Tordera, 109-119, Palafolls, 08389 Barcelona, Spain
Initial Date of Registration : 2020-01-31
Latest Date of Registration :
NDC Package Code : 53484-001
Start Marketing Date : 2009-08-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R1-CEP 2006-209 - Rev 04
Issue Date : 2021-11-10
Type : Chemical and TSE
Substance Number : 2064
Status : Valid
Registrant Name : Donggu Biopharmaceutical Co., Ltd.
Registration Date : 2016-02-25
Registration Number : 20131119-173-I-277-03(7)
Manufacturer Name : Bioiberica, SAU
Manufacturer Address : C/ Antic Camí de Tordera, 109-119 08389 Palafolls (Barcelona), Spain
Certificate Number : CEP 2024-106 - Rev 00
Issue Date : 2024-05-14
Type : Chemical
Substance Number : 2064
Status : Valid
Registrant Name : Donggu Biopharmaceutical Co., Ltd.
Registration Date : 2016-02-25
Registration Number : 20131119-173-I-277-03(7)
Manufacturer Name : Bioiberica, SAU
Manufacturer Address : C/ Antic Camí de Tordera, 109-119 08389 Palafolls (Barcelona), Spain
Certificate Number : R1-CEP 2001-063 - Rev 06
Issue Date : 2022-10-26
Type : TSE
Substance Number : 2064
Status : Valid
Registrant Name : Donggu Biopharmaceutical Co., Ltd.
Registration Date : 2016-02-25
Registration Number : 20131119-173-I-277-03(7)
Manufacturer Name : Bioiberica, SAU
Manufacturer Address : C/ Antic Camí de Tordera, 109-119 08389 Palafolls (Barcelona), Spain
Certificate Number : CEP 2023-243 - Rev 01
Issue Date : 2023-10-24
Type : Chemical and TSE
Substance Number : 2064
Status : Valid
Registrant Name : Donggu Biopharmaceutical Co., Ltd.
Registration Date : 2016-02-25
Registration Number : 20131119-173-I-277-03(7)
Manufacturer Name : Bioiberica, SAU
Manufacturer Address : C/ Antic Camí de Tordera, 109-119 08389 Palafolls (Barcelona), Spain
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26680
Submission : 2013-01-07
Status : Active
Type : II
NDC Package Code : 53484-001
Start Marketing Date : 2009-08-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31738
Submission : 2017-05-17
Status : Active
Type : II
NDC Package Code : 53484-001
Start Marketing Date : 2009-08-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Complete
Rev. Date : 2013-05-09
Pay. Date : 2013-04-26
DMF Number : 17838
Submission : 2004-11-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31738
Submission : 2017-05-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26680
Submission : 2013-01-07
Status : Active
Type : II
Details:
New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Lead Product(s): Hyaluronic Acid,Dermatan Sulfate,Collagen
Therapeutic Area: Dermatology Brand Name: Dermial
Study Phase: PreclinicalProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 25, 2022
Lead Product(s) : Hyaluronic Acid,Dermatan Sulfate,Collagen
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health
Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Brand Name : Dermial
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 25, 2022
Details:
By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient products across the country.
Lead Product(s): Undenatured Type II Collagen
Therapeutic Area: Musculoskeletal Brand Name: Collavant n2
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: ByHealth
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership March 11, 2022
Lead Product(s) : Undenatured Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Partner/Sponsor/Collaborator : ByHealth
Deal Size : Undisclosed
Deal Type : Partnership
New Partnership With ByHealth in China
Details : By partnering with Bioiberica, ByHealth aims to capitalise on the untapped potential of new product development with native type II collagen and respond to the growing number of consumers looking to support their mobility with effective, convenient produ...
Brand Name : Collavant n2
Molecule Type : Large molecule
Upfront Cash : Undisclosed
March 11, 2022
Details:
Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.
Lead Product(s): Chondroitin Sulfate Sodium
Therapeutic Area: Musculoskeletal Brand Name: CSbioactive
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 05, 2021
Lead Product(s) : Chondroitin Sulfate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Bioiberica Rebrands Its Range of Nutraceutical Ingredients for Healthcare
Details : Bioiberica’s native (undenatured) type II collagen, Collavant® n2 (previously b2-Cool®) and the addition of Tendaxion® - a new brand for its tendon health ingredient.
Brand Name : CSbioactive
Molecule Type : Small molecule
Upfront Cash : Not Applicable
July 05, 2021
Details:
Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint function.
Lead Product(s): Hyaluronic Acid,Type II Collagen
Therapeutic Area: Musculoskeletal Brand Name: Motilex HA
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Apsen
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership April 26, 2021
Lead Product(s) : Hyaluronic Acid,Type II Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Apsen
Deal Size : Undisclosed
Deal Type : Partnership
Bioiberica and Apsen Reinforce Partnership with New Holistic Mobility Product–Motilex HA
Details : Apsen’s Motilex HA combines two leading ingredients, b-2Cool native type II collagen and Mobilee, patented ingredient that synergistically combines a high concentration of hyaluronic acid with polysaccharides and collagen, to effectively maintain joint...
Brand Name : Motilex HA
Molecule Type : Small molecule
Upfront Cash : Undisclosed
April 26, 2021
Details:
The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract rich in hyaluronic acid.
Lead Product(s): Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid
Therapeutic Area: Musculoskeletal Brand Name: Mobilee
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 07, 2020
Lead Product(s) : Undenatured Type II Collagen,Chondroitin Sulfate Sodium,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
New Study Further Validates Bioiberica’s B-2cool® Native Type II Collagen as Trusted Source for...
Details : The study, conducted in a rabbit model of osteoarthritis, set out to evaluate the effects of b-2Cool native type II collagen in combination with CS b-Bioactive chondroitin sulphate, glucosamine hydrochloride and Mobilee® which is a rooster comb extract ...
Brand Name : Mobilee
Molecule Type : Large molecule
Upfront Cash : Not Applicable
September 07, 2020
Details:
B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.
Lead Product(s): Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area: Musculoskeletal Brand Name: Colnatur Forte
Study Phase: ApprovedProduct Type: Large molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 15, 2020
Lead Product(s) : Undenatured Type II Collagen,Harpagophytum Procumbens Extract,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Laboratorios Ordesa Incorporates B-2cool®, Bioiberica’s Native Type II Collagen, in Its New Col...
Details : B-2Cool (Bioiberica’s native type II collagen) is an innovative ingredient, has been shown in four scientific studies to help maintain good joint health at a very low daily dose.
Brand Name : Colnatur Forte
Molecule Type : Large molecule
Upfront Cash : Not Applicable
July 15, 2020
Details:
Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.
Lead Product(s): Hyaluronic Acid,Type II Collagen,Polysaccharide
Therapeutic Area: Musculoskeletal Brand Name: Meritene Mobilis
Study Phase: UndisclosedProduct Type: Small molecule
Recipient: Nestle Health Sciences SA
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership June 16, 2020
Lead Product(s) : Hyaluronic Acid,Type II Collagen,Polysaccharide
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Nestle Health Sciences SA
Deal Size : Undisclosed
Deal Type : Partnership
Nestlé Health Science Partners with Bioiberica to Deliver Innovative Nutrition in Joint Health an...
Details : Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix.
Brand Name : Meritene Mobilis
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 16, 2020
Details:
Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.
Lead Product(s): Chondroitin Sulfate Sodium,Glucosamine,Hyaluronic Acid
Therapeutic Area: Musculoskeletal Brand Name: Condrovet
Study Phase: ApprovedProduct Type: Small molecule
Recipient: Bayer AG
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 09, 2020
Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine,Hyaluronic Acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Recipient : Bayer AG
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.
Brand Name : Condrovet
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 09, 2020
Excipients
Inspections and registrations
ABOUT THIS PAGE
Bioiberica is a supplier offers 11 products (APIs, Excipients or Intermediates).
Find a price of Heparin Sodium bulk with DMF, JDMF offered by Bioiberica
Find a price of Chondroitin Sulfate Sodium bulk with CEP offered by Bioiberica
Find a price of Heparin Sodium bulk with DMF offered by Bioiberica
Find a price of Glucosamine bulk offered by Bioiberica
Find a price of Glucosamine Hydrochloride bulk offered by Bioiberica
Find a price of Glucosamine Sulfate Potassium Chloride bulk offered by Bioiberica
Find a price of Glucosamine Sulfate Sodium Chloride bulk offered by Bioiberica
Find a price of Heparin Lithium bulk offered by Bioiberica
Find a price of Levothyroxine Sodium bulk offered by Bioiberica
Find a price of Liothyronine Sodium bulk offered by Bioiberica
Find a price of Thyroid bulk offered by Bioiberica
LOOKING FOR A SUPPLIER?